AI is speeding up clinical trials in 2025 by improving planning, site selection, and patient retention, leading to a 14.2% rise in completed trials.

As of October 2025, AI is accelerating clinical research by improving trial planning, site selection, and patient retention, with tools like Sitetrove+ and Trialtrove+ helping teams reduce screen failures and boost enrollment. A 14.2% rise in completed industry trials in 2024 reflects growing success from data-driven strategies, supported by updated ICH E6(R3) guidelines. Companies like Merck are integrating AI into modernized platforms to streamline operations, enhance inclusivity, and speed trials, while prioritizing ethical use, transparency, and human-centered design to build trust and ensure equitable outcomes.